CINDY WADE: Open Payments
NPI 1013672849 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 48 payments from 18 companies in 2025. Trend: 2023 $230 · 2024 $986 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $194 |
| GlaxoSmithKline, LLC. | 3 | $150 |
| ABBVIE INC. | 4 | $150 |
| Amgen Inc. | 3 | $146 |
| PFIZER INC. | 1 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Lilly USA, LLC | 5 | $105 |
| Astellas Pharma US Inc | 3 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Exact Sciences Corporation | 2 | $51 |
Products named: REXULTI, AREXVY, QULIPTA, REPATHA, PREVNAR 20, Veozah, MOUNJARO, Wegovy.
Industry payments across PA — which companies pay providers there.
